{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:16:49Z","timestamp":1781194609189,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006785","name":"Google","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.retram.2025.103498","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:26:53Z","timestamp":1738672013000},"page":"103498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["AI-assisted computational screening and docking simulation prioritize marine natural products for small-molecule PCSK9 inhibition"],"prefix":"10.1016","volume":"73","author":[{"given":"Neelakandan","family":"Annamalai Ramalakshmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthu Kumar","family":"Thirunavukkarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayaz","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Navami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-997X","authenticated-orcid":false,"given":"Rajanikant","family":"Golgodu Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.retram.2025.103498_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1747493020972922","article-title":"Stroke in COVID-19: a systematic review and meta-analysis","volume":"16","author":"Nannoni","year":"2021","journal-title":"Int J Stroke"},{"issue":"8","key":"10.1016\/j.retram.2025.103498_bib0002","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3174\/ajnr.A6650","article-title":"COVID-19 is an independent risk factor for acute ischemic stroke","volume":"41","author":"Belani","year":"2020","journal-title":"Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.retram.2025.103498_bib0003","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/STROKEAHA.120.031786","article-title":"Acute ischemic stroke and COVID-19: an analysis of 27 676 patients","volume":"52","author":"Qureshi","year":"2021","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.retram.2025.103498_bib0004","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1194\/jlr.R026658","article-title":"The PCSK9 decade: thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases","volume":"53","author":"Lambert","year":"2012","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.retram.2025.103498_bib0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/joim.13210","article-title":"PCSK9 inhibitors for COVID-19: an opportunity to enhance the antiviral action of interferon in patients with hypercholesterolaemia","volume":"289","author":"Vuorio","year":"2020","journal-title":"J Intern Med"},{"issue":"10","key":"10.1016\/j.retram.2025.103498_bib0006","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/13543784.2021.1985463","article-title":"Emerging agents for the treatment and prevention of stroke: progress in clinical trials","volume":"30","author":"Safouris","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"issue":"7","key":"10.1016\/j.retram.2025.103498_bib0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11910-022-01197-4","article-title":"Lipid-modifying therapies and stroke prevention","volume":"22","author":"Hackam","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"10.1016\/j.retram.2025.103498_bib0008","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1586\/14779072.2014.954551","article-title":"Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction","volume":"12","author":"Tavori","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"18","key":"10.1016\/j.retram.2025.103498_bib0009","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2025.103498_bib0010","article-title":"Clinicaltrials.Gov","year":"2024","journal-title":"Clinicaltrials.gov (n.d.)"},{"key":"10.1016\/j.retram.2025.103498_bib0011","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00125-016-4178-y","article-title":"PCSK9 inhibition: the dawn of a new age in cholesterol lowering?","volume":"60","author":"Preiss","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.retram.2025.103498_bib0012","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40273-015-0355-y","article-title":"PCSK9 inhibitors: a technology worth paying for?","volume":"34","author":"Weintraub","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.retram.2025.103498_bib0013","article-title":"Cardiovascular outcomes of PCSK9 inhibitors: with special emphasis on its effect beyond LDL-cholesterol lowering","volume":"2018","author":"Bandyopadhyay","year":"2018","journal-title":"J Lipids"},{"key":"10.1016\/j.retram.2025.103498_bib0014","first-page":"191","article-title":"Safety and tolerability of PCSK9 inhibitors: current insights","author":"Kosmas","year":"2020","journal-title":"Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.retram.2025.103498_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v9.i2.76","article-title":"PCSK9 inhibitors: a new era of lipid lowering therapy","volume":"9","author":"Chaudhary","year":"2017","journal-title":"World J Cardiol"},{"issue":"10106","key":"10.1016\/j.retram.2025.103498_bib0016","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.retram.2025.103498_bib0017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1039\/C4MB00486H","article-title":"Molecular insights of protein contour recognition with ligand pharmacophoric sites through combinatorial library design and MD simulation in validating HTLV-1 PR inhibitors","volume":"11","author":"Selvaraj","year":"2015","journal-title":"Mol Biosyst"},{"issue":"6","key":"10.1016\/j.retram.2025.103498_bib0018","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/07391102.2016.1183520","article-title":"Structural insight into selective phosphodiesterase 4B inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations","volume":"35","author":"Sharma","year":"2017","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.retram.2025.103498_bib0019","first-page":"14","article-title":"An improved force field for folded and intrinsically disordered proteins","author":"Huang","year":"2017","journal-title":"Biophys J"},{"issue":"16","key":"10.1016\/j.retram.2025.103498_bib0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"issue":"45","key":"10.1016\/j.retram.2025.103498_bib0021","doi-asserted-by":"crossref","first-page":"8982","DOI":"10.1021\/acs.jpca.8b09867","article-title":"Small molecule thermochemistry: a tool for empirical force field development","volume":"122","author":"Van der Spoel","year":"2018","journal-title":"J Phys Chem A"},{"issue":"10","key":"10.1016\/j.retram.2025.103498_bib0022","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3390\/ijms20102568","article-title":"Molecular docking and molecular dynamics (MD) simulation of human anti-complement factor H (CFH) antibody Ab42 and CFH polypeptide","volume":"20","author":"Yang","year":"2019","journal-title":"In Int J Mol Sci"},{"key":"10.1016\/j.retram.2025.103498_bib0023","series-title":"2022 Seventh international conference on parallel, distributed and grid computing (PDGC)","first-page":"552","article-title":"Molecular dynamics simulation for serial and parallel computation using leaf frog algorithm","author":"Mandal","year":"2022"},{"key":"10.1016\/j.retram.2025.103498_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43044-021-00150-z","article-title":"The relation between ApoB\/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome","volume":"73","author":"Yaseen","year":"2021","journal-title":"Egypt Heart J"},{"issue":"3","key":"10.1016\/j.retram.2025.103498_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.26425","article-title":"ApoB and non-HDL cholesterol versus LDL cholesterol for ischemic stroke risk","volume":"92","author":"Johannesen","year":"2022","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.retram.2025.103498_bib0026","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1080\/07391102.2020.1751300","article-title":"In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel","volume":"39","author":"Gupta","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"15","key":"10.1016\/j.retram.2025.103498_bib0027","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1080\/07391102.2019.1682052","article-title":"Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1)","volume":"38","author":"Amir","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.retram.2025.103498_bib0028","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijbiomac.2018.09.089","article-title":"Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase","volume":"122","author":"Gulzar","year":"2019","journal-title":"Int J Biol Macromol"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318625000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:34:29Z","timestamp":1762626869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318625000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2452318625000078"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2025.103498","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-assisted computational screening and docking simulation prioritize marine natural products for small-molecule PCSK9 inhibition","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2025.103498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103498"}}